| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 05/08/2007 | US7214800 2-(Imidazol-1-ylalkyl)-3H-quinazolin-4-one derivatives; mitotic kinesin KSP inhibitors; anticarcinogenic, antiinflammatory, and antiproliferative agents |
| 05/08/2007 | US7214798 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; analgesics |
| 05/08/2007 | US7214698 Beta-agonists, processes for preparing them and their use as pharmaceutical compositions |
| 05/08/2007 | US7214694 Controlling transforming growth facor; artificial skin; wound healing agents |
| 05/08/2007 | US7214681 Tri(cyclo) substituted amide compounds |
| 05/08/2007 | US7214676 Spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 05/08/2007 | US7214675 Administering the compound N-{2-[2-(4-amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)ethoxy]ethyl}morpholine-4-carboxamide inducing cytokine biosynthesis; Viricides; anticancer agents; immunology moderators |
| 05/08/2007 | US7214674 Heterocyclymethylpiperidines and -piperazines possessing affinity at 5ht-1 type receptors |
| 05/03/2007 | WO2007049224A1 Novel hexahydro- or octahydro-cyclopenta[c]pyrrole derivatives |
| 05/03/2007 | WO2007048788A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 05/03/2007 | WO2007048732A1 Use of 5-aminopyrazoles for controlling phytopathogenic harmful fungi, novel 5-aminopyrazoles, process for their preparation and composition comprising them |
| 05/03/2007 | WO2007030939A3 Methods of modulating neurotrophin-mediated activity |
| 05/03/2007 | WO2007023110A3 P38 map kinase inhibitors and methods for using the same |
| 05/03/2007 | WO2007021711A3 Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands |
| 05/03/2007 | WO2007009120A3 Heterotetracyclic compounds as tpo mimetics |
| 05/03/2007 | WO2006123257A3 Phenyl-3-{(3-(1h-pyrrol-2-yl)-[1, 2 , 4]0xadiaz0l-5-yl]piperidin-1-yl}-methanone derivatives and related compounds as positive allosteric modulators of metabotropic glutamate receptors |
| 05/03/2007 | WO2006122072A3 Processes for preparing biaryl ureas and analogs thereof |
| 05/03/2007 | WO2006111560A3 2,3 substituted pyrazine sulfonamides as inhibitors of crth2 |
| 05/03/2007 | US20070100141 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
| 05/03/2007 | US20070099964 1, 3, 4-oxadiazol-2-ones as peroxisome-proliferator activated receptor delta modulators and their use in the treatment of neurological and metabolic disease |
| 05/03/2007 | US20070099955 3-piperidinylisochroman-5-ols as dopamine agonists |
| 05/03/2007 | US20070099944 ROCK-1 kinase and/or Aurora kinase inhibitors; indazolo-tetrahydropyrimidine-carboxamide derivatives; 4-(4-fluorophenyl)-N-1H-indazol-5-yl-6-methyl-2-oxo-1,2,3,4-tetrahydro-5-pyrimidinecarboxamide; antiinflammatory, antidiabetic, antiproliferative agents |
| 05/03/2007 | US20070099922 For use as anticoagulant agents for therapy of thromboembolic disorders; 6-chloro-naphthalene-2-sulfonic acid [1-(1-cyclopentyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide; )-2-methyl-benzothiazole-6-sulfonic acid [1-(1-isopropyl-piperidin-4-yl)-2-oxo-pyrrolidin-3-yl]-amide |
| 05/03/2007 | US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/03/2007 | US20070099917 Novel inhibitors and methods for their preparation |
| 05/03/2007 | US20070099916 nuclear hormone receptor inhibitors; to treat increased lipid levels, increased cholesterol levels, low HDL-cholesterol, high LDL-cholesterol, atherosclerotic diseases, diabetes, macular degeneration, Alzheimer's disease; 2-(1-benzyl-3-chloro-2-methyl-1H-indol-5-yl)-1,1,1,3,3,3-hexafluoro-propan-2-ol |
| 05/03/2007 | US20070099913 Pyrrolidinyl beta-amino amide-based inhibitors of dipeptidyl peptidase IV and methods |
| 05/03/2007 | US20070099908 Arylsulfonyl chromans as 5-HT6 inhibitors |
| 05/03/2007 | US20070099903 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions |
| 05/03/2007 | US20070099897 Therapeutic compounds |
| 05/03/2007 | US20070099892 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 05/03/2007 | US20070099874 Methods and compositions of novel triazine compounds |
| 05/03/2007 | CA2627486A1 Novel indole-containing beta agonists, method for producing them and their use as drugs |
| 05/03/2007 | CA2623879A1 Sulfonamide derivatives and use thereof for the modulation of metalloproteinases |
| 05/02/2007 | EP1780201A2 Phenylalanine enamide derivatives possessing a cyclobutene group, for use as integrin inhibitors |
| 05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
| 05/02/2007 | EP1778683A1 Thiophene derivatives, their manufacture and use as pharmaceutical agents |
| 05/02/2007 | EP1778682A1 Heterocyclic compounds useful as dpp- iv inhibitors |
| 05/02/2007 | EP1778681A1 2,4,6-trisubstituted pyrimidines as phosphotidylinositol (pi) 3-kinase inhibitors and their use in the treatment of cancer |
| 05/02/2007 | EP1778677A1 Heterocyclic condensed compounds useful as antidiuretic agents |
| 05/02/2007 | EP1778676A1 Hydantoin derivatives for the treatment of inflammatory disorders |
| 05/02/2007 | EP1778671A1 Piperazine derivatives with ccr3 inhibiting activity |
| 05/02/2007 | EP1778653A1 Biaryl heterocyclic compounds and methods of making and using the same |
| 05/02/2007 | EP1778648A2 Compounds useful for inhibiting chk1 |
| 05/02/2007 | EP1778646A1 Mercaptoimidazoles as ccr2 receptor antagonists |
| 05/02/2007 | EP1778643A1 Tetrahydrobenzazepines as antagonists and/or reverse agonists of the histamine h3 receptor |
| 05/02/2007 | EP1778642A1 5-ht7 receptor antagonosts |
| 05/02/2007 | EP1778641A1 5-ht7 receptor antagonists |
| 05/02/2007 | EP1778634A1 Isoindolone compounds and their use as metabotropic glutamate receptor potentiators |
| 05/02/2007 | EP1778233A1 Intracellular receptor modulator compounds and methods |
| 05/02/2007 | EP1778229A2 Amido compounds and their use as pharmaceuticals |
| 05/02/2007 | EP1778206A2 Small molecule inhibitors of anti-apoptotic bcl-2 family members and the uses thereof |
| 05/02/2007 | EP1658285B1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 05/02/2007 | EP1641787B1 Substituted diketopiperazines and their use as oxytocyn antagonists |
| 05/02/2007 | EP1608645B1 Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses |
| 05/02/2007 | EP1575942B1 compounds having selective inhibiting efect at gsk3 |
| 05/02/2007 | EP1537111B1 Hetereoaryl nitrile derivatives |
| 05/02/2007 | EP1395606B1 Pyrrolidin-2-one derivatives as inhibitors of factor xa |
| 05/02/2007 | EP1358184B1 N-(3,3-Dimethylindolin-6-yl){2-[(4-pyridylmethyl)amino}(3-pyridyl)}carboxamide and pharmaceutical compositions thereof. |
| 05/02/2007 | EP1313716B1 Oxazolyl-arylpropionic acid derivatives and their use as ppar agonists |
| 05/02/2007 | CN1956984A 1,3,4-oxadiazol-2-ones as PPAR-delta modulators |
| 05/02/2007 | CN1956980A Mercaptoimidazoles as CCR2 receptor antagonists |
| 05/02/2007 | CN1956976A Mercaptoimidazoles as CCR2 receptor antagonists |
| 05/02/2007 | CN1956958A Aminopyridine derivatives as selective dopamine d3 agonists |
| 05/02/2007 | CN1956954A Novel androgens |
| 05/02/2007 | CN1956238A Luminescent element material and luminescent element comprising the same |
| 05/02/2007 | CN1956237A Luminescent element material and luminescent element comprising the same |
| 05/02/2007 | CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 05/02/2007 | CN1313465C Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 05/02/2007 | CN1313464C Substituted alkylamine derivatives, preparing method thereof, composition comprising same and use thereof |
| 05/02/2007 | CN1313450C Tachykinin receptor antagonists |
| 05/02/2007 | CN1313448C Metalloproteinase inhibitors |
| 05/01/2007 | US7211695 Trans-1,4-bis{N-[2-(4-hydroxy-3-hydroxymethylphenyl)-2-hydroxyethyl]amino}cyclohexane from aminating a dihydroxymethyl phenyl ketone with a diaminophenylene compound and a reducing agent; treating respiratory diseases, asthma, bronchitis, nervous system injury, premature labor |
| 05/01/2007 | US7211673 5-methyl-2-(4-trifluoromethyl-1H-1-pyrazolyl)-4-(5-trifluoromethyl-3-thienyloxy)pyrimidine; broadleaf herbicide |
| 05/01/2007 | US7211672 PGD2 receptor antagonists for the treatment of inflammatory diseases |
| 05/01/2007 | US7211668 PNA monomer and precursor |
| 05/01/2007 | US7211594 Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
| 05/01/2007 | US7211591 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient |
| 05/01/2007 | US7211587 Administering compounds such as N-{3-Chloro-4-[(6,7-dimethoxy-4-quinolyl)-oxy]phenyl}-N'-(3-isoxazolyl)urea for therapy of malignant tumors |
| 05/01/2007 | US7211586 Substituted tetrahydroisoquinolines |
| 05/01/2007 | US7211576 Diaminothiazoles |
| 05/01/2007 | US7211575 Methods of treating cytokine mediated diseases |
| 05/01/2007 | US7211545 Imidazo[1,2-a]pyrimidine and fungicidal compositions containing thereof |
| 05/01/2007 | CA2244836C Benzoheterocyclic derivatives as antidiabetic and antiobesity agents |
| 05/01/2007 | CA2162630C Sulfonamides |
| 05/01/2007 | CA2132131C 3-arylbenzofuranones as stabilisers |
| 04/26/2007 | WO2007047991A1 Tetrahydroisoquinoline as lxr modulators |
| 04/26/2007 | WO2007047202A1 Substituted heterocyclic compounds with cxcr3 antagonist activity |
| 04/26/2007 | WO2007046550A1 Pyrazole compounds having cannabinoid receptor (cb1) antagonizing activity |
| 04/26/2007 | WO2007045893A2 Beta adrenergic receptor pharmacophore |
| 04/26/2007 | WO2007045861A1 Cinnoline compounds as inhibitors of phosphodiesterase type iv (pde4) |
| 04/26/2007 | WO2007045339A1 Imidazole derivatives as inhibitors of tafia |
| 04/26/2007 | WO2007027230A3 Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses |
| 04/26/2007 | WO2006135828A3 Trisubstituted amines as phosphodiesterase 4 inhibitors |
| 04/26/2007 | WO2006133216A3 4-substituted arylamine derivatives and their use in pharmaceutical compositions |
| 04/26/2007 | WO2005115991A8 Anti-cytokine heterocyclic compounds |
| 04/26/2007 | WO2004069139A3 4-aminopyrimidin-5-yl-methanone derivatives for inhibition of cdk4 activity |
| 04/26/2007 | US20070093535 Vinyl phenyl derivatives as GLK activators |
| 04/26/2007 | US20070093534 Modulation of Pathogenicity |
| 04/26/2007 | US20070093529 Diacylhydrazine derivatives |